JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

LONG-TERM OUTCOMES OF FASCIOTOMY FOR ACUTE COMPARTMENT SYNDROME FOLLOWING A FRACTURE OF THE TIBIAL DIAPHYSIS.

OBJECTIVES: To evaluate the short- and long-term patient reported outcomes of acute compartment syndrome (ACS) complicating a fracture of the tibial diaphysis.

DESIGN: Retrospective review.

SETTING: Academic orthopaedic trauma centre.

PATIENTS: We retrospectively identified 559 patients from a trauma database over a 7-year period. Forty-one patients (7.3%) underwent fasciotomies for ACS and were included in the study. A matched cohort of 185 patients who did not develop ACS were used as controls.

INTERVENTION: Fasciotomy for ACS.

MAIN OUTCOME MEASUREMENTS: The primary short-term outcome measure was the development of complications, including infection, non-union and further surgery. The primary long-term outcome measure was the patient reported Euroqol-5D-3L (EQ-5D). Secondary long-term outcomes included the Oxford Knee Score (OKS), the Manchester-Oxford Foot Questionnaire (MOXFQ) and satisfaction.

RESULTS: There was no significant difference between ACS and non-ACS groups in the overall rate of infection (17% vs 9.2% respectively; p=0.14), deep infection (4.9% vs 3.8%; p=0.67) or non-union (4.9% vs 7.0%; p=1.00). There were 206 patients (21 ACS) with long-term outcome data at a mean of 5 years (1-9). There was no significant difference between groups with respect to the EQ-5D (p=0.81), OKS (p=0.24) or MOXFQ (p=0.63). Patient satisfaction was reduced in patients who developed ACS (77 vs 88; p=0.039).

CONCLUSION: These data suggest that when managed with urgent decompressive fasciotomies, ACS does not appear to have a significant impact on long-term patient reported outcome, although patient satisfaction is reduced.

LEVEL OF EVIDENCE: III - Retrospective cohort study.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app